Pharma company lawsuit forces Dutch health agency to reassess cancer drug

9 July 2024 - The Dutch healthcare procurement agency has said it will reassess the breast cancer drug abemaciclib after ...

Read more →

Dutch Minister plans to implement new reimbursement system for high cost medicine

27 June 2024 - Concerns have been raised about the relative effectiveness of an increasing number of new medicines at ...

Read more →

Make medicines affordable - without going to court

11 July 2023 - Governments can and must take control to prevent extreme drug prices. ...

Read more →

Dutch Ministry Of Health will not reimburse Gilead’s breast cancer drug, Trodelvy

1 May 2023 - Last month, the Dutch Ministry of Health, Welfare and Sport (VWS) announced that it will not ...

Read more →

Medicine and medical device pricing and reimbursement in Netherlands

2 March 2023 - Since the Netherlands is a Member State of the European Union, it has implemented the European ...

Read more →

Anti-viral COVID-19 treatment now available in the Netherlands for 1,250 Euros

1 December 2022 - The anti-viral medication approved to treat COVID-19 is now available on the Dutch market, the Dutch Association ...

Read more →

High demand of popular obesity drug Saxenda; may be going to "wrong" patients

26 November 2022 - Since April of this year there has been a high demand for the obesity drug Saxenda, but ...

Read more →

Amryt receives reimbursement approval from the Dutch Ministry of Health for Myalepta (metreleptin)

17 October 2022 - Amryt receives reimbursement approval from the Dutch Ministry of Health for Myalepta (metreleptin). ...

Read more →

Doctors, patients protest at plans to cap medicine prices

23 September 2022 - Doctors, pharmacists and patients organisations are angry about government plans to cut spending on medicine, which ...

Read more →

Key considerations in the health technology assessment of advanced therapy medicinal products in Scotland, The Netherlands and England

8 March 2022 - Advanced therapy medicinal products are highly innovative therapies. Their costs and uncertain value claims have raised concerns ...

Read more →

Dutch health insurance: what changes in 2022?

11 November 2021 - The Dutch healthcare institute Zorginstituut Nederland is going to increase its monitoring of treatment to better ...

Read more →

Patients in the Netherlands wait 1.5 years for access to new medicines

2 September 2021 - Patients in the Netherlands have to wait an average of 510 days for access to a new ...

Read more →

Hansa Biopharma announces reimbursement in the Netherlands of Idefirix (imlifidase) as desensitisation treatment for highly sensitised kidney transplant patients

2 August 2021 - Idefiris (imlifidase) for enabling kidney transplantation in highly sensitised patients is now reimbursable and available for use ...

Read more →

Dutch advisory group says Zolgensma shouldn’t be covered unless Novartis halves price

10 May 2021 - In a challenge to Novartis, a Dutch advisory body has recommended that the government not cover ...

Read more →

World’s most expensive drug may not be covered by Dutch insurance

7 May 2021 - A drug to treat a rare muscle disease which affects some 20 children in the Netherlands ...

Read more →